![NATtrol™ Respiratory Syncytial Virus Type A Stock](http://www.diagnostictechnology.com.au/cdn/shop/products/image_a295a795-b19d-4763-b8cd-ef0f0cc2f0a9_1024x1024.jpg?v=1603690953)
NATtrol™ Respiratory Syncytial Virus Type A Stock
NATRSVA-STQContact us for more information.
PRODUCT DESCRIPTION:
NATtrol™ Respiratory Syncytial Virus Type A Stock is formulated with purified, intact viral particles that have been chemically modified to render them non-infectious and refrigerator stable. Each vial contains 1.0 mL of NATtrol™ Respiratory Syncytial Virus Type A stock in a proprietary matrix at the target concentration listed in Table 1.
INTENDED USE:
NATtrol™ Respiratory Syncytial Virus Type A stock is designed to evaluate the performance of nucleic acid tests for determination of the presence of Respiratory Syncytial Virus A nucleic acid. NATtrol™ Respiratory Syncytial Virus A stock enables laboratories to monitor test variation, lot-to-lot test kit performance, operator variation, and can provide assistance In identifying random or systemic error.